4.4 Article

Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy

Letizia Porcelli et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2015)

Article Oncology

TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

Sandeep Rajput et al.

MOLECULAR CANCER THERAPEUTICS (2013)

Review Pharmacology & Pharmacy

Challenging resistance mechanisms to therapies for metastatic melanoma

Lucio Tentori et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2013)

Article Oncology

Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations

Paul K. Paik et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)